HY-P5284-5mg
|
MedChemexpress LLC
|
RALA peptide [CAS 1613231-49-4]
|
|
|
|
HY-126721-10mg
|
MedChemexpress LLC
|
Tetralysine [CAS 997-20-6]
|
|
|
|
HY-126721-5mg
|
MedChemexpress LLC
|
Tetralysine [CAS 997-20-6]
|
|
|
|
HY-B2049-100mg
|
MedChemexpress LLC
|
TrifluMu ron [CAS 64628-44-0]
|
|
COVID-19-immunoregulation
|
|
HY-B2049-50mg
|
MedChemexpress LLC
|
TrifluMu ron [CAS 64628-44-0]
|
|
COVID-19-immunoregulation
|
|
HY-147087-10mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-100mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-25mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-5mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-50mg
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0]
|
|
Cancer-programmed cell death
|
|
HY-147087-1mL
|
MedChemexpress LLC
|
YSK 05 [CAS 1318793-78-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|